First randomized phase 3 clinical trial of neoadjuvant immunotherapy in patients with kidney cancer

by ECOG-ACRIN Cancer Research GroupCredit: Pixabay/CC0 Public DomainThe ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) will present data from PROSPER RCC (EA8143), the first randomized phase 3 trial of

Updated on: January 04,2024

First randomized phase 3 clinical trial of neoadjuvant immunotherapy in patients with kidney cancer

by ECOG-ACRIN Cancer Research GroupCredit: Pixabay/CC0 Public DomainThe ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) will present data from PROSPER RCC (EA8143), the first randomized phase 3 trial of

Updated on:January 04,2024

Study finds 'startling' inequities in end-of-life opioid treatment

byHarvard UniversityCredit: Unsplash/CC0 Public DomainOlder Black and Hispanic patients with advanced cancer are less likely than white patients to receive opioid medications for pain relief in

Updated on: January 23,2024

Study finds 'startling' inequities in end-of-life opioid treatment

byHarvard UniversityCredit: Unsplash/CC0 Public DomainOlder Black and Hispanic patients with advanced cancer are less likely than white patients to receive opioid medications for pain relief in

Updated on:January 23,2024

Breast cancer patients with higher BMI more likely to experience heart damage during chemotherapy, study finds

byAmerican College of CardiologyCredit: Unsplash/CC0 Public DomainBreast cancer survival rates have improved considerably in the last few decades in Colombia, but factors that increase the likel

Updated on: January 23,2024

Breast cancer patients with higher BMI more likely to experience heart damage during chemotherapy, study finds

byAmerican College of CardiologyCredit: Unsplash/CC0 Public DomainBreast cancer survival rates have improved considerably in the last few decades in Colombia, but factors that increase the likel

Updated on:January 23,2024

'Synthetic immune niche' approach enhances T-cell proliferation without compromising cancer-killing ability

byWeizmann Institute of ScienceComparison of the significant differences in gene expression profiles between DC-activated cells (orange dots) and bead-activated cells (black dots) on their '

Updated on: September 28,2024

'Synthetic immune niche' approach enhances T-cell proliferation without compromising cancer-killing ability

byWeizmann Institute of ScienceComparison of the significant differences in gene expression profiles between DC-activated cells (orange dots) and bead-activated cells (black dots) on their '

Updated on:September 28,2024

New screening tool to explore mechanisms behind cancer, autoimmunity and neurodegeneration

by Jelena Pupavac,Wellcome Trust Sanger InstituteA single-cell base editor screen tiling acrossJAK1is improved by coupling genotype with transcriptome.aUMAP of LoF and no

Updated on: April 23,2024

New screening tool to explore mechanisms behind cancer, autoimmunity and neurodegeneration

by Jelena Pupavac,Wellcome Trust Sanger InstituteA single-cell base editor screen tiling acrossJAK1is improved by coupling genotype with transcriptome.aUMAP of LoF and no

Updated on:April 23,2024

Cancer patients diagnosed early are more likely to avoid chemotherapy

by Cancer Research UKCredit: Cancer Research UKCancer patients are around five times more likely to have surgery to remove their tumour, and less likely to have chemotherapy, if they are diagnose

Updated on: April 20,2024

Cancer patients diagnosed early are more likely to avoid chemotherapy

by Cancer Research UKCredit: Cancer Research UKCancer patients are around five times more likely to have surgery to remove their tumour, and less likely to have chemotherapy, if they are diagnose

Updated on:April 20,2024

Researchers use skin-colonizing bacteria to create a topical cancer therapy in mice

by Hadley Leggett,Stanford University Medical CenterCredit: AI-generated imageWhile studying a type of bacteria that lives on the healthy skin of every human being, researchers from Stanford Med

Updated on: February 18,2024

Researchers use skin-colonizing bacteria to create a topical cancer therapy in mice

by Hadley Leggett,Stanford University Medical CenterCredit: AI-generated imageWhile studying a type of bacteria that lives on the healthy skin of every human being, researchers from Stanford Med

Updated on:February 18,2024

Researchers identify neurotransmitter that helps cancers progress

by Johns Hopkins University School of MedicineUsing human cancer cells, tumor and blood samples from cancer patients, researchers at Johns Hopkins Medicine have uncovered the role of a neurotrans

Updated on: June 15,2024

Researchers identify neurotransmitter that helps cancers progress

by Johns Hopkins University School of MedicineUsing human cancer cells, tumor and blood samples from cancer patients, researchers at Johns Hopkins Medicine have uncovered the role of a neurotrans

Updated on:June 15,2024

Glioma subtypes determine how the dangerous tumors spread, evade anti-angiogenic treatment

by Massachusetts General HospitalTumorous glial cells, labeled in green, have overtaken most of an adult fly brain. Glial cell nuclei are shown in red. Credit: Courtesy of Dr. Renee Read, Salk In

Updated on: March 01,2024

Glioma subtypes determine how the dangerous tumors spread, evade anti-angiogenic treatment

by Massachusetts General HospitalTumorous glial cells, labeled in green, have overtaken most of an adult fly brain. Glial cell nuclei are shown in red. Credit: Courtesy of Dr. Renee Read, Salk In

Updated on:March 01,2024

Gut bacteria engineered to act as tumor GPS for immunotherapies

byDana-Farber Cancer InstituteBacteria displaying hDR18 enhance anti-tumor responses of MSLN-CAR NK cells. Credit:Nature Biotechnology(2024). DOI: 10.1038/s41587-024-02418-6Immunothe

Updated on: October 10,2024

Gut bacteria engineered to act as tumor GPS for immunotherapies

byDana-Farber Cancer InstituteBacteria displaying hDR18 enhance anti-tumor responses of MSLN-CAR NK cells. Credit:Nature Biotechnology(2024). DOI: 10.1038/s41587-024-02418-6Immunothe

Updated on:October 10,2024

Virus-targeting white blood cells in tumors offer intriguing insights into responsiveness to immunotherapy

by Agency for Science, Technology and Research (A*STAR), SingaporeGreen and red tumor-infiltrating lymphocytes expressing CD39 in human lung cancer. Credit: A*STAR Singapore Immunology NetworkBys

Updated on: March 06,2024

Virus-targeting white blood cells in tumors offer intriguing insights into responsiveness to immunotherapy

by Agency for Science, Technology and Research (A*STAR), SingaporeGreen and red tumor-infiltrating lymphocytes expressing CD39 in human lung cancer. Credit: A*STAR Singapore Immunology NetworkBys

Updated on:March 06,2024

Old chemo drug, new pancreatic cancer therapy?

Updated on: September 10,2024

Old chemo drug, new pancreatic cancer therapy?

Updated on:September 10,2024